Standout Papers
Immediate Impact
4 from Science/Nature 103 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Engineered commensals for targeted nose-to-brain drug delivery
2025 Standout
Works of James Thrasher being referenced
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| James Thrasher | 450 | 177 | 292 | 20 | 598 | |
| Whitney Sealls | 412 | 166 | 317 | 13 | 629 | |
| M. Nauck | 428 | 271 | 181 | 25 | 715 | |
| Marie‐Louise Hartoft‐Nielsen | 423 | 96 | 225 | 17 | 609 | |
| Paolo Pinna Parpaglia | 308 | 180 | 169 | 26 | 720 | |
| Kimberly M. Hoagland | 413 | 101 | 226 | 16 | 728 | |
| Richard Urquhart | 373 | 117 | 473 | 15 | 703 | |
| Amanda Garza | 264 | 113 | 240 | 28 | 563 | |
| Xiaosu Ma | 390 | 205 | 161 | 21 | 567 | |
| Andrea Delbarba | 262 | 120 | 167 | 23 | 604 | |
| Hisashi Yokomizo | 271 | 172 | 257 | 26 | 714 |
All Works
Loading papers...